Jaspers Y, Yska H, Bergner C, Dijkstra I, Huffnagel I, Voermans M
Commun Med (Lond). 2024; 4(1):175.
PMID: 39256476
PMC: 11387402.
DOI: 10.1038/s43856-024-00605-9.
Kleiboeker B, Lodhi I
Mol Metab. 2022; 65:101577.
PMID: 35988716
PMC: 9442330.
DOI: 10.1016/j.molmet.2022.101577.
Jaspers Y, Ferdinandusse S, Dijkstra I, Barendsen R, van Lenthe H, Kulik W
Front Cell Dev Biol. 2020; 8:690.
PMID: 32903870
PMC: 7438929.
DOI: 10.3389/fcell.2020.00690.
Wu C, Iwamoto T, Igarashi J, Miyajima T, Hossain M, Yanagisawa H
Mol Genet Metab Rep. 2017; 12:115-118.
PMID: 28725571
PMC: 5506878.
DOI: 10.1016/j.ymgmr.2017.06.004.
Muneer Z, Wiesinger C, Voigtlander T, Werner H, Berger J, Forss-Petter S
PLoS One. 2014; 9(9):e108655.
PMID: 25255441
PMC: 4177892.
DOI: 10.1371/journal.pone.0108655.
X-linked adrenoleukodystrophy: pathogenesis and treatment.
Engelen M, Kemp S, Poll-The B
Curr Neurol Neurosci Rep. 2014; 14(10):486.
PMID: 25115486
DOI: 10.1007/s11910-014-0486-0.
Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes.
Singh J, Khan M, Singh I
Biochim Biophys Acta. 2013; 1831(4):747-58.
PMID: 23318275
PMC: 3607212.
DOI: 10.1016/j.bbalip.2013.01.004.
Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation.
Engelen M, Schackmann M, Ofman R, Sanders R, Dijkstra I, Houten S
J Inherit Metab Dis. 2012; 35(6):1137-45.
PMID: 22447153
PMC: 3470694.
DOI: 10.1007/s10545-012-9471-4.
Is subclinical adrenal failure in adrenoleukodystrophy/adrenomyeloneuropathy reversible?.
Cappa M, Bizzarri C, Giannone G, Aiello C, di Biase A
J Endocrinol Invest. 2011; 34(10):753-6.
PMID: 21399389
DOI: 10.3275/7570.
Biochemical aspects of X-linked adrenoleukodystrophy.
Kemp S, Wanders R
Brain Pathol. 2010; 20(4):831-7.
PMID: 20626744
PMC: 8094824.
DOI: 10.1111/j.1750-3639.2010.00391.x.
The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy.
Ofman R, Dijkstra I, van Roermund C, Burger N, Turkenburg M, van Cruchten A
EMBO Mol Med. 2010; 2(3):90-7.
PMID: 20166112
PMC: 3377275.
DOI: 10.1002/emmm.201000061.
Metabolism of trideuterated iso-lignoceric acid in rats in vivo and in human fibroblasts in culture.
Poulos A, Stockham P, Johnson D, Paton B, Beckman K, Singh H
Lipids. 1999; 34(9):943-9.
PMID: 10574659
DOI: 10.1007/s11745-999-0444-y.
A mouse model for X-linked adrenoleukodystrophy.
Lu J, Lawler A, Watkins P, Powers J, Moser A, Moser H
Proc Natl Acad Sci U S A. 1997; 94(17):9366-71.
PMID: 9256488
PMC: 23196.
DOI: 10.1073/pnas.94.17.9366.
X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.
van Geel B, Assies J, Wanders R, Barth P
J Neurol Neurosurg Psychiatry. 1997; 63(1):4-14.
PMID: 9221959
PMC: 2169642.
DOI: 10.1136/jnnp.63.1.4.
Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil).
Rasmussen M, Moser A, Borel J, Khangoora S, Moser H
Neurochem Res. 1994; 19(8):1073-82.
PMID: 7800117
DOI: 10.1007/BF00968719.
Very long chain fatty acids in higher animals--a review.
Poulos A
Lipids. 1995; 30(1):1-14.
PMID: 7760683
DOI: 10.1007/BF02537036.
Komrower Lecture. Adrenoleukodystrophy: natural history, treatment and outcome.
Moser H
J Inherit Metab Dis. 1995; 18(4):435-47.
PMID: 7494402
DOI: 10.1007/BF00710055.
Neonatal adrenoleukodystrophy: clinical, pathologic, and biochemical delineation of a syndrome affecting both males and females.
Jaffe R, Crumrine P, Hashida Y, Moser H
Am J Pathol. 1982; 108(1):100-11.
PMID: 7091298
PMC: 1916022.
Acyl-CoA cholesterol acyltransferase in cultured glioblastoma cells.
Jeng I, Klemm N
Neurochem Res. 1984; 9(9):1193-210.
PMID: 6504235
DOI: 10.1007/BF00973034.
Accumulation of hydrocarbon in a patient with adrenoleukodystrophy.
Miki H, Matsuzawa Y, Ishibe T, Ishikawa K, Moriwaki K, Takahashi M
J Neurol. 1983; 229(1):1-10.
PMID: 6189972
DOI: 10.1007/BF00313491.
